Long-Term Safety of Elagolix With Add-Back in Women With Endometriosis-Associated Pain: 36-Month Results

被引:0
|
作者
Simon, James [1 ]
Kim, Jin Hee [1 ]
Miller, Paul [1 ]
Ng, Juki [1 ]
Snabes, Michael [1 ]
Thomas, James [1 ]
机构
[1] George Washington Univ, Washington, DC USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
1368036
引用
收藏
页码:13S / 13S
页数:1
相关论文
共 50 条
  • [41] The Role of Physical Activity in Long-term Weight Loss: 36-month Results From a Randomized Controlled Trial
    Butryn, Meghan L.
    Crane, Nicole T.
    Lufburrow, Emily
    Hagerman, Charlotte J.
    Forman, Evan M.
    Zhang, Fengqing
    ANNALS OF BEHAVIORAL MEDICINE, 2023, 57 (02) : 146 - 154
  • [42] THE IMPACT OF ELAGOLIX ON QUALITY OF LIFE IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM TWO RANDOMIZED, PLACEBO-CONTROLLED STUDIES USING THE ENDOMETRIOSIS HEALTH PROFILE QUESTIONNAIRE.
    Taylor, H. S.
    Surrey, E.
    Soliman, A. M.
    Castelli-Haley, J.
    Rowan, J. P.
    Chwalisz, K.
    Thomas, J. W.
    Schwefel, B.
    Williams, L. A.
    Jain, R. I.
    FERTILITY AND STERILITY, 2016, 106 (03) : E93 - E93
  • [43] Long-term persistence and switching patterns among women using osteoporosis therapies: 24-and 36-month results from POSSIBLE US™
    Wade, S. W.
    Satram-Hoang, S.
    Stolshek, B. S.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (09) : 2279 - 2290
  • [44] Exposure-Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis-Associated Pain
    Suleiman, Ahmed Abbas
    Nader, Ahmed
    Winzenborg, Insa
    Beck, Denise
    Polepally, Akshanth R.
    Ng, Juki
    Noertersheuser, Peter
    Mostafa, Nael M.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (11): : 639 - 648
  • [45] Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™
    S. W. Wade
    S. Satram-Hoang
    B. S. Stolshek
    Osteoporosis International, 2014, 25 : 2279 - 2290
  • [46] Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials
    Pokrzywinski, Robin M.
    Soliman, Ahmed M.
    Chen, Jun
    Snabes, Michael
    Diamond, Michael P.
    Surrey, Eric
    Coyne, Karin S.
    FERTILITY AND STERILITY, 2019, 112 (03) : 545 - 551
  • [47] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN FAMILIAL MEDITERRANEAN FEVER (FMF)-36-MONTH DATA FROM THE RELIANCE REGISTRY
    Henes, J.
    Blank, N.
    Krickau, T.
    Pankow, A.
    Foeldvari, I.
    Dressler, F.
    Horneff, G.
    Kallinich, T.
    Oommen, P.
    Meier, F.
    Weller-Heinemann, F.
    Kortus-Goetze, B.
    Hufnagel, M.
    Rech, J.
    Andreica, I.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1160 - 1161
  • [48] Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS
    Reed, Catherine
    Belger, Mark
    Scott Andrews, J.
    Tockhorn-Heidenreich, Antje
    Jones, Roy W.
    Wimo, Anders
    Dodel, Richard
    Haro, Josep Maria
    INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 (02) : 267 - 277
  • [49] Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study
    Crawford, Thomas O.
    Day, John W.
    De Vivo, Darryl C.
    Krueger, Jena M.
    Mercuri, Eugenio
    Nascimento, Andres
    Pasternak, Amy
    Mazzone, Elena Stacy
    Duong, Tina
    Song, Guochen
    Marantz, Jing L.
    Baver, Scott
    Yu, Dongzi
    Liu, Lan
    Darras, Basil T.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [50] Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis
    Mustafa Ali
    Aruna Kumari Hira
    Haris Jawaid
    Faiza Zakaria
    Zehra Somjee
    Middle East Fertility Society Journal, 26